Earnings Feed
Start Free
Lexaria Bioscience Corp.·4

May 16, 5:39 PM ET

BUNKA CHRISTOPHER 4

4 · Lexaria Bioscience Corp. · Filed May 16, 2025

Insider Transaction Report

Form 4
Period: 2025-05-15
Lexaria Bioscience Corp.LEXX
BUNKA CHRISTOPHER
Director
Transactions
  • Award

    Stock Options

    2025-05-15+11,000→ 184,834 total
    Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (11,000 underlying)
Holdings

  • common shares

    373,543

  • common shares

    (indirect: Private Holding Company)
    254,412

  • Stock Options

    Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying)
    26,000

  • Stock Options

    Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying)
    49,334

  • Stock Options

    Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
    64,334

  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
    94,334

  • Stock Options

    Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying)
    124,334

  • Stock Options

    Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying)
    173,834
Footnotes (1)
  • [F1]100,000 common shares were issued as a restricted stock award that is subject to escrow provisions until July 7, 2025.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT